Why the study?
Does positioning the transvenous anode in the left brachiocephalic vein compared to the superior vena cava improve the defibrillation threshold in patients undergoing defibrillator implantation?
Does positioning the transvenous anode in the left brachiocephalic vein compared to the superior vena cava improve the defibrillation threshold in patients undergoing defibrillator implantation?
Answers are grounded in this paper and cite their sources.
Positioning the defibrillation anode in the left brachiocephalic vein does not generally improve defibrillation thresholds compared to the standard superior vena cava position, though individual patients may benefit.
For most nonthoracotomy defibrillation lead systems, the transvenous anode can positioned independently of the right ventricular (RV) cathode. Usually a vertical position in the superior vena cava (SVC) is chosen. However, it is unknown if this position yields the optimal defibrillation threshold (DFT). Therefore, in 15 patients undergoing defibrillator implantation the SVC position was compared in a crossover study design with a horizontal position in the left brachiocephalic vein (BCV). Mean DFT was not different for SVC and BCV (19.2 +/- 9.6 J vs 18.5 +/- 9.1 J) but DFT of individual patients differed by up to 12 joules. A positive correlation between impedance and DFT in the BCV position (r = 0.6; P < or = 0.05) indicated that the improved geometry of the defibrillation field with the BCV position is opposed by a higher impedance found for this position (63 +/- 15 omega vs 52 +/- 7 omega). Thus, defibrillation is not improved in general although individual patients might benefit.
No takes yet. Share an insight, caveat, or question.
Block et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: